Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Peritoneal Neoplasms × 1 year × Clear all

Phase

Status

Sponsor Class

OTHER 31 INDUSTRY 11 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Prostatic Neoplasms 25 Carcinoma, Non-Small-Cell Lung 22 Neoplasms 21 Multiple Myeloma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Melanoma 13 Lymphoma 13 Colorectal Neoplasms 12 Leukemia, Myeloid, Acute 11 Lung Neoplasms 10 Neoplasm Metastasis 8 Medulloblastoma 8 Lymphoma, Non-Hodgkin 8 Hodgkin Disease 8 HIV Infections 8 Brain Neoplasms 8 Neuroblastoma 7 Leukemia 7 Hematologic Neoplasms 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Pancreatic Neoplasms 6 Myelodysplastic Syndromes 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Leukemia, Biphenotypic, Acute 6 Ependymoma 6 Central Nervous System Neoplasms 6 Carcinoma, Renal Cell 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡